期刊文献+

呼吸困难可视模拟评分在AECOPD中指导激素使用的价值 被引量:9

Application value of dyspnea visual analog scale in directing glucocorticoid usage in AECOPD patients
在线阅读 下载PDF
导出
摘要 目的探讨呼吸困难可视模拟评分在AECOPD病人中的临床使用价值,初步评估其在指导糖皮质激素使用方面的作用。方法收集2013年12月至2014年5月符合条件的AECOPD病人69例,在患者入院后及出院前24小时内采用呼吸困难可视Analog问卷、改良后Borg’s评分及英国医学研究学会的呼吸困难量表(m MRC)对病人进行评估,并收集实验室生化指标包括CRP,血气分析等。统计患者住院总时间及激素使用总时间,并分析激素治疗与患者呼吸困难评分之间的相关性。结果入院可视Analog问卷与Borg评分间有良好的一致性(r=0.936,P<0.01),与m MRC评分间呈相关性(r=0.527,P<0.01)。治疗前后患者VAS问卷明显下降;入院可视Analog问卷得分值与激素使用之间呈正相关(r=0.706,P<0.01),相关回归分析示回归系数b=1.505,P<0.01。结论可视Analog问卷(VAS)具有准确评估患者呼吸困难的作用,临床上可用于指导AECOPD患者激素使用。 Objective To analyze the application of dyspnea VAS in the management of patients with AE-COPD, and to explore the value of the preliminary VAS assessment in guiding hormone use of AECOPD. Methods&amp;nbsp;69 AECOPD patients completed VAS, Modified Borg’s score (MBS), and modified Medical Research Council 24 hours before admission and discharge. The concentration of serum C-reactive protein ( CRP) , blood gas analysis, the duration of hospital stay and time exposed to glucocorticoid therapy were analyzed. Correlations between VAS, MBS and hormone therapy were examined. Results VAS at admission remained a good consistency with Borg score ( r=0. 936, P〈0. 01), and a moderate correlation with mMRC score (r=0. 527, P〈0. 01). After hormonal therapy, VAS and Modified Borg’ s score decreased significantly. VAS at admission was positively correlated with the duration of glucocorticoid usage (r=0. 706, P〈0. 01). Conclusion VAS at admission can exactly assess AECOPD pa-tients’ dyspnea, which can guide the usage of glucocorticoid.
出处 《临床肺科杂志》 2014年第12期2153-2156,共4页 Journal of Clinical Pulmonary Medicine
关键词 肺疾病 慢性阻塞性 呼吸困难 糖皮质激素 pulmonary disease chronic obstructive dyspnea glucocorticoid
作者简介 通讯作者:胡杰贵,E-mail:hujiegui52@163.com
  • 相关文献

参考文献16

  • 1慢性阻塞性肺疾病诊治指南(2013年修订版)[J].中华结核和呼吸杂志,2013,36(4):255-264. 被引量:3876
  • 2Pere Almagro, Pablo Martinnea-Camblor, Joan B. Soriano, et al. (2014) Finding the Best Thresholds of FEV1 and Dyspnea to Pre liet 5-Year Survival in COPD Patients: The COCOMICS Study[J]. PLOS ONE 9 (2) : e89866, doi: 10. 1371/journal. pone. 0089866.
  • 3Mark B. Parshall, Richard M. Schwartzstein, Lewis Adams, et al. An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea [ J ]. Am J Respir Crit Care Med ,2012 ; 185 (4) :435 - 452.
  • 4乔人立,Bruce L Davidson,Darcy Marciniuk.有关慢性阻塞性肺疾病的几个值得关注的问题[J].中华结核和呼吸杂志,2012,35(1):73-74. 被引量:17
  • 5Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoid on exacerbations of chronic obstrcutive pulmonary disease. Department of Veterans Affairs Cooperative Study Group [J]. N Engl J ned. 1999;340(25) :1942 -1947.
  • 6Wang PH, Cheng SL, Wang HC. Systemic steroids in acute exacer- bation of COPD-from guidelines to bedside[ J ]. International Jour- nal of Clinical Pharmacology and Therapeutics, 2011,49 ( 11 ) :705 - 708.
  • 7Global Strategy For The Diagnosis, Management, And Prevention Of Chronic Obstructive Pulmonary Disease (revised 2014 ) [OL ]. ht- tp ://www. goldcopd, org/Global Initiative for Chronic Obstructive Lung disease.
  • 8Aaron SD,Vandemheen KL, Hebert P,et al. Outpatient oral pred- nisone after emergency treatment of chronic obstrcutive pulmonary disease [ J ]. N Engl J Med, 2003,348 ( 26 ) :2618 - 2625.
  • 9Woods JA, Wheeler JS, Finch CK, et al. Corticosteroids in the treatment of Acute exacerbations of chronic obstructive pulmonary disease[ J]. International Journal of COPD,2014:9:421 - 430.
  • 10蔡柏蔷.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案)[J].中华哮喘杂志(电子版),2013,7(1):1-13. 被引量:195

二级参考文献53

共引文献4125

同被引文献71

引证文献9

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部